Corticosteroids in Duchenne muscular dystrophy: impact on the motor function measure sensitivity to change and implications for clinical trials

Schreiber A, Brochard S, Rippert P, Fontaine-Carbonnel S, Payan C, Poirot I, Hamroun D, Vuillerot C 
Dev Med Child Neurol. 2018. 60(2):185-191.
 
The aim of the study was to monitor the evolution of the motor function of ambulatory patients with Duchenne muscular dystrophy (DMD) treated by corticosteroids for 2 years in comparison with untreated patients.
Significant differences were found between mean MFM D1, D2 and D3 scores in corticosteroids-treated and untreated groups bewteen 0 and 6 months and between 0 and 24 month. For MFM D1 specifically, there was a significant increase in the corticosteroids-treated group (mean slope of change=12.6±15.5%/y), while a decrease was observed in the untreated group (mean slope of change=-17.8±17.7%/y) between 0 months and 6 months.

PubMed link

Keywords: Duchenne muscular dystrophy, corticosteroids, Motor Function Measure

Articles dans les revues scientifiques

Short-TERM Neuromuscular Electrical Stimulation Training of the Tibialis Anterior Did Not Improve Strength and Motor Function in Facioscapulohumeral Muscular Dystrophy Patients

Doix AM, Roeleveld K, Garcia J, Lahaut P, Tanant V, Fournier-Mehouas M, Desnuelle C, Colson SS, Sacconi S Am J Phys Med Rehabil. 2017. 96(4):e56-e63. Prospective study including 10 patients with facioscapulohumeral muscular dystrophy type 1 (FSHD1) and 10 healthy...

read more